Clinical Trials Sponsored by Dario Parini

Total 5048 results

Dario Parini

Unknown

Multicentric Study About Pathological Risk Factors for Lymph Node Metastasis in Malignant Colorectal Polyps (POST-1)

Colorectal Cancer | Colorectal Polyp | Lymph Node Metastasis

Italy
Dario Valcarenghi

Completed

Mepitel Film Treatment for the Prevention and Cutaneous Toxicity Due to Radiotherapy

Post-surgery Radiotherapy

Switzerland
Università degli Studi di Sassari
Dr. Dario Melodia; Dr. Milena Pisano; Dr. Aurea Lumbau; Prof. Silvio Mario Meloni; Prof. Edoardo Baldoni

Not yet recruiting

Comparison KS Versus TS

Dental Implant | Dental Implant-Abutment Design

Italy
Università degli Studi di Sassari
Dr. Dario Melodia; Dr. Milena Pisano; Dr. Aurea Lumbau; Prof. Silvio Mario Meloni; Prof. Edoardo Baldoni

Not yet recruiting

RCT GBR One Stages Comparing A-Oss and Autogenous Bone Versus A-Oss and LCR-A

Dental Implant | Guided Bone Regeneration

Italy
Università degli Studi di Sassari
Dr. Dario Melodia; Dr. Milena Pisano; Dr. Aurea Lumbau; Prof. Silvio Mario Meloni; Prof. Edoardo Baldoni

Not yet recruiting

RCT Comparing KS Versus TS for Ovedenture

Dental Implant | Dental Implant-Abutment Design | Edentulous Jaw
Carina Mari Aparici

Withdrawn

68Ga Citrate PET/MRI for Evaluation of Fever of Unknown Origin (FUO)

Fever of Unknown Origin

United States
Pain Therapeutics

Completed

Study to Evaluate the Subjective Effects of PTI-801 in Non-Physically Dependent Subjects With a History of Drug Abuse

Opioid-Related Disorders

United States
Pain Therapeutics

Completed

Effects of Food on Oxycodone Pharmacokinetics in Healthy Volunteers

Healthy

United States
Pain Therapeutics

Completed

Long-term Safety of PF-00345439 (Oxycodone)

Pain
Pain Therapeutics

Completed

Pharmacokinetics And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers

Healthy

United States
Pain Therapeutics

Completed

Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma

Metastatic Melanoma

Israel
Università degli Studi di Sassari
Dr. Dario Melodia; Dr. Milena Pisano; Prof. Silvio Mario Meloni; Prof. Edoardo... and other collaborators

Not yet recruiting

SOI Immediately vs Delayed

Dental Implant | Dental Implant-Abutment Design

Italy
Università degli Studi di Sassari
Dr. Dario Melodia; Dr. Milena Pisano; Prof. Silvio Mario Meloni; Prof. Edoardo... and other collaborators

Not yet recruiting

Soi TS3 Surface in Patients With and Without Type 2 Diabetes

Dental Implant | Dental Implant-Abutment Design

Italy
Mario Ammirati

Withdrawn

The Evaluation of Clevidipine in Patients Requiring ICP Monitoring and IV Antihypertensive Therapy

Hypertension

United States
Consorzio Mario Negri Sud
LifeScan

Completed

Role Of Self-monitoring of Blood Glucose and Intensive Education in Patients With Type 2 Diabetes Not Receiving Insulin (ROSES)

Type 2 Diabetes

Italy
Pain Therapeutics

Completed

Single-Dose, Crossover Study To Compare Bioavailability Of Two Formulations Under Fed And Fasted Conditions

Healthy

United States
Pain Therapeutics

Completed

Dose Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma

Metastatic Melanoma

Israel
Monia Lorini
Mario Negri Institute for Pharmacological Research

Recruiting

MSC Therapy in Liver Transplantation

Liver Transplant Rejection

Italy
Monia Lorini
Mario Negri Institute for Pharmacological Research

Unknown

MSC and Kidney Transplant Tolerance (Phase A)

Chronic Renal Failure

Italy
Università degli Studi di Sassari
Dr. Dario Melodia; Dr. Milena Pisano; Prof. Silvio Mario Meloni; Prof. Edoardo... and other collaborators

Not yet recruiting

RCT KS-SA Versur KS-BA in Diabetic Patients

Diabetes | Dental Implant

Italy
Monia Lorini
Istituto Di Ricerche Farmacologiche Mario Negri

Unknown

ACE-inhibitors in Extracapillary Glomerulonephritis (EXTRA)

Extracapillary Glomerulonephritis

Italy
Johns Hopkins University
Dalio Foundation

Completed

Oral Cannabidiol for Opioid Withdrawal

Opioid Use Disorder | Opioid Withdrawal | Opioid Craving

United States
Xention Ltd
Ario Pharma Ltd

Completed

A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With Chronic Idiopathic Cough

Chronic Idiopathic Cough

United Kingdom, Ireland
Mario Negri Institute for Pharmacological Research

Not yet recruiting

1 vs 7 RATG Infusions in Renal Transplantation (ONSET)

Kidney Replacement

Italy
Mario Negri Institute for Pharmacological Research

Not yet recruiting

An Outcome Analysis of Primary Membranous Nephropathy (PROMENADE)

Membranous Nephropathy

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

New Analytic Tools for aHUS and C3G Diagnosis (COMPRare)

Healthy | Hemolytic-Uremic Syndrome | Membranoproliferative Glomerulonephritis

Italy
Mario Widmer

Recruiting

Effectiveness of a Powered Exoskeleton Combined With FES for Patients With Chronic SCI: a RCT (Ekso-FES)

Spinal Cord Injuries | Gait Disorders, Neurologic

Switzerland
Mario Negri Institute for Pharmacological Research

Recruiting

Severe Acquired Brain Injuries: Prognostic Factors and Quality of Care

Brain Injuries, Acute

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Evaluation of ATRA Activity in Combination With Anastrozole in Pre-operative Phase of Operable Early Breast Cancer (ATRA)

Breast Neoplasm Female

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Autoreactive B Cells in Membranous Nephropathy (PEPTIDE)

Membranous Nephropathy

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Colorectal Carcinoma. CHECK Study. (CHECK)

Colorectal Neoplasms

Italy
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Admissions of Patients Accessing the Emergency Department (Fondazione IRCCS Ca' Granda Ospedale Maggione Policlinico)

Emergency Department | Evaluation | Quality of Care | Appropriateness

Italy
Mario Boccadoro

Active, not recruiting

STUDY THAT COMPARE 3 ARM: MLN9708 DEXAMETHASONE, MLN9708 CYCLOPHOSPHAMIDE AND DEXAMETHASONE, MLN9708 THALIDOMIDE AND DEXAMETHASONE FOLLOWED BY MAINTENANCE WITH MLN9708 IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA PATIENTS

Multiple Myeloma

Italy
Mario Negri Institute for Pharmacological Research

Completed

Diadem to Investigate the Activity and Safety of Durvalumab (Diadem)

Pleura Mesothelioma

Italy
Mario Negri Institute for Pharmacological Research

Completed

Early CPAP in COVID-19 Patients With Respiratory Failure. (EC-COVID-RCT)

COVID-19 | Emergency Departments | CPAP Ventilation

Italy
Mario Negri Institute for Pharmacological Research

Completed

Early CPAP in COVID-19 Patients With Respiratory Failure. A Prospective Cohort Study. (EC-COVID-PCS)

Early CPAP Ventilation in COVID-19 Patients

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation (RAFTING)

Rheumatoid Arthritis

Italy
Mario Negri Institute for Pharmacological Research

Completed

Nephrolithiasis Prevention by Lemon Juice (LIMONE)

Nephrolithiasis

Italy
Mario Negri Institute for Pharmacological Research

Terminated

the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line Treatment (VICTOR3)

Triple Negative Breast Cancer

Spain, Italy, Portugal
Mario Negri Institute for Pharmacological Research

Completed

GREAT - Good Response With Appropriate Treatment

Neoplasms | Cancer Pain

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

Italy
Mario Negri Institute for Pharmacological Research

Completed

Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND)

Type 2 Diabetes

Italy, Slovenia
Mario Negri Institute for Pharmacological Research

Terminated

ITACA-S2 (Intergroup Trial in Adjuvant Chemotherapy for Adenocarcinoma of the Stomach) (ITACA-S2)

Gastric Adenocarcinoma

Italy
Mario Negri Institute for Pharmacological Research

Completed

CE-US in Renal Transplantation

Renal Transplantation

Italy
Mario Negri Institute for Pharmacological Research

Completed

Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study (ALADIN)

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Italy
Consorzio Mario Negri Sud
Sanofi; LifeScan

Unknown

Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice (DID3)

Type 1 Diabetes

Italy
Mario Negri Institute for Pharmacological Research

Completed

Ezetimibe and Simvastatin in Dyslipidemia of Diabetes

Type 2 Diabetes

Italy
Mario Negri Institute for Pharmacological Research

Completed

L-Arginine in Pre-Eclampsia

Pre-Eclampsia

Italy
Mario Negri Institute for Pharmacological Research

Completed

Low Dose Sirolimus or CsA-Based Maintenance Immunosuppression After Induction With Campath-1 in Kidney Transplantation

Kidney Transplant

Italy
Mario Negri Institute for Pharmacological Research

Not yet recruiting

Kidney Perfusion With or Without Absorption (POWER)

Kidney Replacement

Italy

Clinical Trials Sponsored by Dario Parini

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations